Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
98.43
(
-1.43%
)
Bitcoin
71,172.02
(
0.56%
)
News Focus
News Focus
Post# of 257392
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 164482

Friday, 07/26/2013 1:50:03 AM

Friday, July 26, 2013 1:50:03 AM

Post# of 257392

Here we go again—partial clinical hold for VX-135, VRTX's in-house nuke, due to elevated liver enzymes





The small studies never made sense in what should have been a very exciting drug. ACHN holders take note. At least VRTX was able to find partners to do oral combo testing with.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today